Severe myelotoxicity of oral etoposide in heavily pretreated patients with non-Hodgkin's lymphoma or chronic lymphatic leukemia. [electronic resource]
Producer: 19960705Description: 2313-7 p. digitalISSN:- 0008-543X
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents, Phytogenic -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Bone Marrow Diseases -- chemically induced
- Disease Progression
- Disease Susceptibility -- chemically induced
- Etoposide -- administration & dosage
- Female
- Gastrointestinal Diseases -- chemically induced
- Humans
- Infections -- etiology
- Leukemia, Lymphocytic, Chronic, B-Cell -- drug therapy
- Leukocyte Count
- Lymphoma, Non-Hodgkin -- drug therapy
- Male
- Middle Aged
- Neutropenia -- chemically induced
- Prednisone -- therapeutic use
- Remission Induction
- Salvage Therapy
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.